Benvenue Medical, Inc.

Benvenue Medical Receives FDA Clearance for Luna XD Minimally Invasive Expandable Interbody Device

Retrieved on: 
Thursday, June 27, 2019
Health, Medical devices, FDA, Surgery, General Health, Medicine, Medical specialties, Surgery, Minimally-invasive surgery, Neurosurgery, Spinal fusion, Alif, Discectomy, MIS, Minimally invasive procedure, Luna XD, Orbit Articulating Discectomy System, Benvenue Medical, Inc.

Benvenue Medical, Inc., an innovative developer of minimally invasive surgery (MIS) expandable implant solutions for lumbar fusions, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the companys enhanced Luna XD MIS expandable interbody device.

Key Points: 
  • Benvenue Medical, Inc., an innovative developer of minimally invasive surgery (MIS) expandable implant solutions for lumbar fusions, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the companys enhanced Luna XD MIS expandable interbody device.
  • View the full release here: https://www.businesswire.com/news/home/20190627005220/en/
    Luna XD MIS Expandable Interbody Device (Photo: Business Wire)
    Luna XD combines anterior lumbar interbody fusion (ALIF) principles with a minimally invasive controlled posterior approach to provide anterior column stability, strength, and fusion in patients with symptomatic degenerative disc disease (DDD).
  • Orbit is a minimally invasive discectomy system that uses a small, posterior incision to achieve efficient disruption, removal of disc tissue and endplate preparation.
  • Benvenue Medical, Inc. is a developer of minimally invasive systems for lumbar fusion guided by the principles of reproducibility, ease-of-use and simplicity.